Menstrual blood-derived stromal stem cells inhibit optimal generation and maturation of human monocyte-derived

Mahmood Bozorgmehr1, Seyed Mohammad Moazzeni2, Mojdeh Salehnia3

  • 1Immunology Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Immunology Letters
|December 3, 2014
PubMed

Insights

Menstrual blood stromal stem cells (MenSCs) inhibit the generation and maturation of dendritic cells (DCs). This immune modulation may involve IL-6 and IL-10, suggesting MenSCs could impact immune responses.

Area of Science:

  • Stem cell biology
  • Immunology
  • Cell biology

Background:

  • Menstrual blood stromal stem cells (MenSCs) show clinical potential but their immune interactions are poorly understood.
  • Dendritic cells (DCs) are crucial for regulating immune responses.

Purpose of the Study:

  • To investigate the effect of MenSCs on the generation and maturation of human blood monocyte-derived dendritic cells (DCs).

Main Methods:

  • MenSCs were isolated from menstrual blood.
  • Monocytes were differentiated into immature (iDC) and mature (mDC) DCs with or without MenSCs.
  • Cell markers, costimulatory molecules, IL-6, and IL-10 were analyzed.

Main Results:

  • MenSCs inhibited monocyte differentiation into iDCs.
  • IL-6 and IL-10 levels were elevated in MenSC-monocyte cocultures.
  • MenSCs hindered the generation of fully mature DCs when added early in the differentiation process.

Conclusions:

  • MenSCs exert an inhibitory impact on DC generation and maturation.
  • Elevated IL-6 and IL-10 may partly mediate this effect.
  • Further research into MenSCs' immunomodulatory potential is warranted.
Abstract